Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome
- PMID: 20031221
- DOI: 10.1016/j.ophtha.2009.08.003
Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome
Abstract
Purpose: To study the effects of intravitreal foscarnet and the clinical differences between varicella zoster virus (VZV) and herpes simplex virus (HSV) induced acute retinal necrosis (ARN).
Design: Retrospective comparative case series.
Participants: Eighty-one eyes of 74 patients.
Methods: A retrospective case note analysis was performed in 2 tertiary referral centers.
Main outcome measures: Presenting and final visual acuity, and progression to retinal detachment.
Results: Thirty-three eyes had HSV-ARN and 48 had VZV-ARN. The average age for HSV-ARN was 34 years and 51 for VZV-ARN (P<0.001). Visual acuity on presentation was similar (P = 0.48), but a larger proportion had better vision (> or =20/60) in the HSV-ARN group (52%) than the VZV-ARN group (35%). A greater proportion of eyes with poor vision (< or =20/200) was found at the 12-month follow-up in the VZV-ARN group (60%) compared with the HSV-ARN group (35%). A greater degree of visual loss in the VZV-ARN group (0.4 logarithm of the minimum angle of resolution [logMAR]) compared with the HSV-ARN group (0.04 logMAR) was detected (P = 0.016). Retinal detachment was 2.5-fold more common in VZV-ARN (62%) compared with HSV-ARN (24%). When comparing eyes treated with (n = 56) and without (n = 25) intravitreal foscarnet, there was a 40% lower rate in retinal detachment (53.6% vs 75.0%) for VZV-ARN (P = 0.23). The numbers with HSV-ARN were too small for analysis.
Conclusions: The results support the difference of outcome in HSV-ARN and VZV-ARN. Therefore, viral identification serves as a key to predicting outcome in these patients. Intravitreal foscarnet seems to be a useful adjunct for the treatment of ARN in that it reduced rate of retinal detachment.
Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Clinical characteristics of acute HSV-2 retinal necrosis.Am J Ophthalmol. 2004 May;137(5):872-9. doi: 10.1016/j.ajo.2003.12.036. Am J Ophthalmol. 2004. PMID: 15126152 Review.
-
Acute retinal necrosis features, management, and outcomes.Ophthalmology. 2007 Apr;114(4):756-62. doi: 10.1016/j.ophtha.2006.08.037. Epub 2006 Dec 20. Ophthalmology. 2007. PMID: 17184841
-
Acute retinal necrosis: clinical features, early vitrectomy, and outcomes.Ophthalmology. 2009 Oct;116(10):1971-5.e2. doi: 10.1016/j.ophtha.2009.03.029. Epub 2009 Jul 9. Ophthalmology. 2009. PMID: 19592111
-
Treatment of Refractory Acute Retinal Necrosis with Intravenous Foscarnet or Cidofovir.Ocul Immunol Inflamm. 2018;26(2):199-203. doi: 10.1080/09273948.2016.1207788. Epub 2016 Sep 6. Ocul Immunol Inflamm. 2018. PMID: 27598973
-
Diagnosis and Treatment of Acute Retinal Necrosis: A Report by the American Academy of Ophthalmology.Ophthalmology. 2017 Mar;124(3):382-392. doi: 10.1016/j.ophtha.2016.11.007. Epub 2017 Jan 13. Ophthalmology. 2017. PMID: 28094044 Review.
Cited by
-
Viral posterior uveitis.Surv Ophthalmol. 2017 Jul-Aug;62(4):404-445. doi: 10.1016/j.survophthal.2016.12.008. Epub 2016 Dec 22. Surv Ophthalmol. 2017. PMID: 28012878 Free PMC article. Review.
-
Atypical acute retinal necrosis accompanied by Terson's syndrome: a case report.BMC Ophthalmol. 2017 Dec 19;17(1):255. doi: 10.1186/s12886-017-0655-4. BMC Ophthalmol. 2017. PMID: 29258454 Free PMC article.
-
Treatment Regimen and Outcomes in Acute Retinal Necrosis: An IRIS® Registry Study.Ophthalmology. 2024 Dec;131(12):1468-1470. doi: 10.1016/j.ophtha.2024.07.020. Epub 2024 Jul 20. Ophthalmology. 2024. PMID: 39033858
-
Clinical characteristics and outcomes of acute retinal necrosis at different stages: a retrospective study.BMC Ophthalmol. 2025 Mar 4;25(1):107. doi: 10.1186/s12886-025-03937-9. BMC Ophthalmol. 2025. PMID: 40038654 Free PMC article.
-
Long-Term Functional Outcomes of Retinal Detachment Due to Acute Retinal Necrosis: A Case Series.Biomedicines. 2024 Oct 11;12(10):2320. doi: 10.3390/biomedicines12102320. Biomedicines. 2024. PMID: 39457631 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical